Kyntra Bio, Inc. (KYNB)
4.85
-0.51
(-9.51%)
USD |
NASDAQ |
Oct 16, 16:00
5.10
+0.25
(+5.15%)
After-Hours: 20:00
Kyntra Bio Net Income (TTM) : -30.91M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.91M |
| March 31, 2026 | -56.57M |
| December 31, 2025 | -58.20M |
| September 30, 2025 | -52.26M |
| June 30, 2025 | -87.41M |
| March 31, 2025 | -120.82M |
| December 31, 2024 | -153.10M |
| September 30, 2024 | -206.97M |
| June 30, 2024 | -222.29M |
| March 31, 2024 | -262.87M |
| December 31, 2023 | -290.53M |
| September 30, 2023 | -294.18M |
| June 30, 2023 | -322.21M |
| March 31, 2023 | -307.15M |
| December 31, 2022 | -293.65M |
| September 30, 2022 | -361.56M |
| June 30, 2022 | -220.11M |
| March 31, 2022 | -281.47M |
| December 31, 2021 | -290.02M |
| September 30, 2021 | -214.58M |
| June 30, 2021 | -231.37M |
| March 31, 2021 | -182.70M |
| December 31, 2020 | -189.29M |
| September 30, 2020 | -228.78M |
| June 30, 2020 | -311.22M |
| Date | Value |
|---|---|
| March 31, 2020 | -109.91M |
| December 31, 2019 | -76.97M |
| September 30, 2019 | 42.10M |
| June 30, 2019 | 48.99M |
| March 31, 2019 | -90.44M |
| December 31, 2018 | -86.42M |
| September 30, 2018 | -141.27M |
| June 30, 2018 | -123.17M |
| March 31, 2018 | -131.66M |
| December 31, 2017 | -120.88M |
| September 30, 2017 | -120.98M |
| June 30, 2017 | -120.68M |
| March 31, 2017 | -64.45M |
| December 31, 2016 | -61.68M |
| September 30, 2016 | -79.05M |
| June 30, 2016 | -99.99M |
| March 31, 2016 | -67.25M |
| December 31, 2015 | -85.78M |
| September 30, 2015 | -84.97M |
| June 30, 2015 | -79.41M |
| March 31, 2015 | -89.63M |
| December 31, 2014 | -59.50M |
| September 30, 2014 | -18.24M |
| June 30, 2014 | 3.118M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Vericel Corp. | 24.22M |
| Nektar Therapeutics | -157.13M |
| Capricor Therapeutics, Inc. | -129.42M |
| ARS Pharmaceuticals, Inc. | -215.43M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |